SCHEMBL13065455

SCHEMBL13065455

CNCc1ccc(CC(=O)NCCN2CCCCC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.67
▸ SMN1; SMN2 Q16637 1/20 0.67
▸ CYP2D6 P10635 3/20 0.67
▸ POLB P06746 2/20 0.57
▸ KMT2A Q03164 5/20 0.54
▸ NCF1 P14598 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.50
▸ CYP3A4 P08684 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ OPRM1 P35372 1/20 0.48
▸ OPRK1 P41145 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16511120 0.90 GAA (0.81) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL16511117 0.89 GAA (0.83) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL825962 0.87 GAA (0.64) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL11985668 0.85 GAA (0.66) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL2822477 0.83 KMT2A (0.76) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL16511119 0.81 ALDH1A1 (0.73) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL16511225 0.80 ALDH1A1 (0.75) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL2822487 0.77 GAA (0.58) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL7644013 0.76 GAA (0.71) GAASMN1; SMN2CYP2D6POLBKMT2A
SCHEMBL5476362 0.76 ALDH1A1 (0.64) GAASMN1; SMN2CYP2D6POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3012254-A1 BIPHENYL DERIVATIVE AND ITS USE FOR TREATING PULMONARY DISORDERS Theravance Respiratory Company, LLC (US) 2016-04-27 — — EP disclosed
EP-2246345-A1 BIPHENYL DERIVATIVES HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Theravance Inc (US) 2010-11-03 — — EP disclosed
Send feedback